Altrafin AG (Ltd.) is a private Asset Management & Investment Advisory Company, incorporated in Zurich, Switzerland. The company was established in 2001 with the objective of providing comprehensive and independent investment advisory services.

Altrafin has a successful track record in providing asset management services and has excellent, international references.

The company acts exclusively for its clients and is independent of banks and other financial institutions.

The Group’s companies Altrafin AG, Altrafin Advisory AG and Altrafin Investment Partners AG are subject to all regulatory provisions applicable in Switzerland to independent asset managers.

As an asset manager of a Swiss investment fund, Altrafin Advisory AG is authorised and regulated directly by the Swiss Financial Market Supervisory Authority (FINMA).

The Group’s auditor is PricewaterhouseCoopers, Zurich.

The Chairman of the Altrafin Group (Altrafin Holding AG) is Dr. iur. Mathis Berger, Attorney at Law, LL.M. The Managing Partners and founders of Altrafin are:

• Patrick Picenoni (MBA/ lic. oec. HSG, University of St.Gallen, Switzerland)
• Alessandro Rizzi, CFA (MBA/ lic. oec. HSG, University of St.Gallen, Switzerland)

Team
The Managing Partners and all team members of Altrafin are former employees of well-known asset management firms (Morgan Stanley), family offices (Beisheim Holding), specialised hedge fund boutiques and professional services firms (PricewaterhouseCoopers). They have a broadly based international know-how and experience in asset management and alternative investments (primarily Hedge Funds).